Insufficient scRNA-seq data for expression of GLI1 at single-cell level.
Insufficient scRNA-seq data for expression of GLI1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 739.73 | 239 / 245 | 86% | 2.57 | 432 / 502 |
intestine | 87% | 349.28 | 840 / 966 | 79% | 3.03 | 414 / 527 |
stomach | 85% | 224.70 | 304 / 359 | 79% | 3.70 | 225 / 286 |
lung | 86% | 259.58 | 499 / 578 | 65% | 3.39 | 756 / 1155 |
bladder | 90% | 790.19 | 19 / 21 | 47% | 1.65 | 236 / 504 |
breast | 84% | 265.20 | 385 / 459 | 41% | 1.06 | 458 / 1118 |
kidney | 79% | 205.81 | 70 / 89 | 46% | 1.43 | 412 / 901 |
uterus | 85% | 718.59 | 144 / 170 | 37% | 2.06 | 172 / 459 |
pancreas | 31% | 54.94 | 103 / 328 | 87% | 7.37 | 154 / 178 |
esophagus | 43% | 105.77 | 623 / 1445 | 63% | 5.15 | 116 / 183 |
skin | 71% | 185.33 | 1283 / 1809 | 31% | 1.04 | 144 / 472 |
thymus | 91% | 413.91 | 592 / 653 | 9% | 0.15 | 56 / 605 |
adrenal gland | 83% | 187.38 | 214 / 258 | 15% | 0.41 | 35 / 230 |
spleen | 94% | 160.76 | 227 / 241 | 0% | 0 | 0 / 0 |
brain | 60% | 146.91 | 1573 / 2642 | 28% | 2.30 | 199 / 705 |
blood vessel | 85% | 237.50 | 1133 / 1335 | 0% | 0 | 0 / 0 |
ovary | 56% | 244.45 | 100 / 180 | 26% | 0.96 | 110 / 430 |
adipose | 66% | 255.25 | 791 / 1204 | 0% | 0 | 0 / 0 |
heart | 62% | 151.02 | 536 / 861 | 0% | 0 | 0 / 0 |
liver | 31% | 37.38 | 71 / 226 | 30% | 0.78 | 121 / 406 |
peripheral blood | 58% | 119.84 | 542 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 0.88 | 16 / 29 |
muscle | 26% | 41.16 | 212 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.63 | 8 / 45 |
eye | 0% | 0 | 0 / 0 | 4% | 0.05 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008589 | Biological process | regulation of smoothened signaling pathway |
GO_0007224 | Biological process | smoothened signaling pathway |
GO_0009954 | Biological process | proximal/distal pattern formation |
GO_0030324 | Biological process | lung development |
GO_1902808 | Biological process | positive regulation of cell cycle G1/S phase transition |
GO_0060032 | Biological process | notochord regression |
GO_0045667 | Biological process | regulation of osteoblast differentiation |
GO_0060045 | Biological process | positive regulation of cardiac muscle cell proliferation |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000345 | Biological process | regulation of hepatocyte proliferation |
GO_0030850 | Biological process | prostate gland development |
GO_0009913 | Biological process | epidermal cell differentiation |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0009953 | Biological process | dorsal/ventral pattern formation |
GO_0045880 | Biological process | positive regulation of smoothened signaling pathway |
GO_0097421 | Biological process | liver regeneration |
GO_0021696 | Biological process | cerebellar cortex morphogenesis |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045740 | Biological process | positive regulation of DNA replication |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0021983 | Biological process | pituitary gland development |
GO_0048546 | Biological process | digestive tract morphogenesis |
GO_0009611 | Biological process | response to wounding |
GO_0007286 | Biological process | spermatid development |
GO_0007418 | Biological process | ventral midline development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005930 | Cellular component | axoneme |
GO_0097542 | Cellular component | ciliary tip |
GO_1990788 | Cellular component | GLI-SUFU complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0097546 | Cellular component | ciliary base |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003682 | Molecular function | chromatin binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0008017 | Molecular function | microtubule binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GLI1 |
Protein name | GLI family zinc finger 1 GLI-Kruppel family member GLI1 splice variant Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI) Glioma-associated oncogene 1 |
Synonyms | GLI |
Description | FUNCTION: Acts as a transcriptional activator . Binds to the DNA consensus sequence 5'-GACCACCCA-3' . Regulates the transcription of specific genes during normal development . Plays a role in craniofacial development and digital development, as well as development of the central nervous system and gastrointestinal tract. Mediates SHH signaling . Plays a role in cell proliferation and differentiation via its role in SHH signaling . .; FUNCTION: [Isoform 2]: Acts as a transcriptional activator, but activates a different set of genes than isoform 1. Activates expression of CD24, unlike isoform 1. Mediates SHH signaling. Promotes cancer cell migration. . |
Accessions | ENST00000532291.5 ENST00000528467.1 [P08151-2] ENST00000528432.1 E9PQQ1 T2HQN2 B1Q2M2 ENST00000228682.7 [P08151-1] ENST00000546141.5 [P08151-2] E9PIB9 P08151 ENST00000543426.5 [P08151-3] |